Cargando…
Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation
BACKGROUND: Tacrolimus is a key drug in immunosuppressive therapy following lung transplantation. The blood tacrolimus levels are likely to fluctuate in the early postoperative period, and failure to maintain the tacrolimus trough level in target ranges is a risk factor for rejection. However, there...
Autores principales: | Katada, Yoshiki, Nakagawa, Shunsaku, Itohara, Kotaro, Suzuki, Takuya, Kato, Ryota, Endo, Hiroki, Sugimoto, Mitsuhiro, Yonezawa, Atsushi, Nakagawa, Takayuki, Ohsumi, Akihiro, Nakajima, Daisuke, Date, Hiroshi, Terada, Tomohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526258/ https://www.ncbi.nlm.nih.gov/pubmed/36180948 http://dx.doi.org/10.1186/s40780-022-00256-9 |
Ejemplares similares
-
Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics
por: Itohara, Kotaro, et al.
Publicado: (2022) -
A case report of a prolonged decrease in tacrolimus clearance due to co-administration of nirmatrelvir/ritonavir in a lung transplant recipient receiving itraconazole prophylaxis
por: Tsuzawa, Ayumi, et al.
Publicado: (2023) -
Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study
por: Ikuta, Keiko, et al.
Publicado: (2022) -
A Minimal Physiologically‐Based Pharmacokinetic Model for Tacrolimus in Living‐Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype
por: Itohara, Kotaro, et al.
Publicado: (2019) -
Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study
por: Ikuta, Keiko, et al.
Publicado: (2021)